Health Canada To Review Adcetris for Hodgkin's, ALCL

Seattle Genetics is announcing that the required validation period has ended and Health Canada has accepted the company's New Drug Submission (NDS) for review for the antibody drug conjugate Adcetris (brentuximab vedotin) for use against relapsed Hodgkin's lymphoma and for systemic anaplastic large cell lymphoma (ALCL).

The NDS is based on data from a pivotal trial in patients with relapsed or refractory Hodgkin's following an autologous stem cell transplantation, and another pivotal trial in patients with relapsed or refractory systemic anaplastic large cell lymphoma.

Health Canada intends to review the NDS under its policy of Notice of Compliance with Conditions (NOC/c). This policy is intended for drugs or treatments that are either meant for conditions for which no other treatment exists in Canada, or for treatments that represent a substantial improvement over existing treatments.

"Data from the pivotal clinical trials of Adcetris in relapsed HL and sALCL demonstrated a high objective response rate and manageable safety profile in heavily pre-treated patients," said Joseph M. Connors, M.D., FRCPC, Clinical Director, Center for Lymphoid Cancer at BC Cancer Agency in Vancouver, Canada. "If approved in Canada, Adcetris would constitute a major step forward in how we are able to treat these patients."

Source: MarketWatch

More Articles

More Articles

Mantle cell lymphoma (MCL) is a rare type of B-Cell lymphoma. It presents itself in the mantle zone of lymph nodes...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

Indolent Lymphoma, or Indolent Non-Hodgkin’s Lymphomas (NHLs), are slow growing, low-grade cancers (as opposed to ...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

Lymphomas are classified based on the type of cells involved. Non-Hodgkin’s lymphomas are marked by mutations of...

Hodgkin's Lymphoma (Disease) has a colorful history: It was not the first cancer discovered but it was one of the first in which treatments were...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Cancer bracelets are undeniably popular, and if purchased through reliable sources such as major charities, they help contribute to the fight...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer of the b- and t-cell lymphocytes, part of the immune system. They account for the most frequent head and neck malignancies....

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

As a kind of cancer, lymphoma attacks the lymphocytes and lymph nodes that are part of the immune system. Head and neck lymphoma results when...

Some cancers have clear environmental causes. Oral cancer is strongly tied to the use of chewing tobacco, and lung cancer is well-known to be much...

The Follicular Lymphoma International Prognostic Index, or FLIPI, is a standardized guide to help oncological diagnosticians accurately calculate...